Introduction Several prognostic indices are in use to stratify chronic myeloid leukemia (CML) patients: Sokal, Hasford, and the European Treatment and Outcome Study (EUTOS) being the most commonly reported ones. The application of different scores may cause variability in the determination of disease prognosis. This study was conducted to stratify patients of CML in accordance with Sokal, Hasford, and EUTOS scoring systems and to determine the concordance rate of risk categories, calculated by using all three scoring systems. Methods This study was conducted at King Edward Medical University from January 2013 to May 2019. A total of 114 patients were diagnosed with CML in the chronic phase during the study period and included in the analysis. Variables of interest were computed using Microsoft Excel. These variables include age, spleen size, platelet count, the percentage of myeloblasts in the peripheral blood, as well as the percentage of basophils and eosinophils in the peripheral blood. Using these baseline variables, the prognostic category of each patient was calculated using Sokal, Hasford, and EUTOS scores. Results The male to female ratio of patients included in the study was 1.43. The mean age was 39.3±1.58 years, with an age range of 13 to 95 years. A total of only 4 out of 73 patients were categorized as a low-risk category, whereas 23 out of 80 patients were categorized into a highrisk category by all three scoring systems. The assignment of prognostic categories was variable, depending on which prognostic score was applied. The concordance rate of Sokal vs Hasford was 53%, Sokal vs EUTOS 64%, and Hasford vs EUTOS 98%. Conclusion There is considerable inter-variability between the various prognostic indicators. In general, the Hasford and EUTOS scores assign some patients to a lower risk category when compared to Sokal score.

Objectives: This study was conducted to find effect of storage time and temperature on platelet indices of samples taken in EDTA. Methods: In this study 100 samples without the specification of gender were included. CBC samples were taken in two EDTA vials from each patient. All the samples were separated in two groups. One sample group was stored at room temperature(RT) and other at 2-6°C. CBC was run on CBC analyzer Sysmex XN-1000 at 0 hours, 4 hours, 12 hours and 24 hours. Results: There was significantly increasing trend for MPV, PDW and P-LCRat RT and decreasing trend at 4°C when compared with 0 hours. PCT showed significant decreasing trend at 4°C with respect to 0 hours. Significant decrease in platelet count was observed after storage at room temperature as well as at 4°C. Conclusion: Although 4°C consider as optimal temperature to transport specimen for CBC but Platelet Indices values varies significantly in comparison to baseline when stored at 4oC and at room temperature. It seems prudent to conclude that if platelet pathology is the major drive for CBC test performance then specimen should be run without delay.